Will Abbott's Absorb Bioresorbable Vascular Scaffold Revolutionize Treatment of Coronary Artery Disease?

In Part One of this feature, we reported on the various positives and negatives of the BVS, as presented to the FDA panel that recommended approval. In this, Part Two, we discuss the Absorb's potential impact in the United States with three leading interventional cardiologists, Drs. Ajay Kirtane, James Blankenship, and Daniel Simon.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news